Beyond dopamine receptor antagonism: New targets for Schizophrenia treatment and prevention (2021)
Gomes, Felipe Villela 
; Grace, Anthony A.
Fonte: International Journal of Molecular Sciences. Unidade: FMRP
Assuntos: AGENTES DOPAMINÉRGICOS, TRANSTORNOS PSICÓTICOS, ESQUIZOFRENIA, HIPOCAMPO, ESTRESSE, GLUTAMATOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GOMES, Felipe Villela e GRACE, Anthony A. Beyond dopamine receptor antagonism: New targets for Schizophrenia treatment and prevention. International Journal of Molecular Sciences, v. 22, n. 9, p. 1-18, 2021Tradução . . Disponível em: https://doi.org/10.3390/ijms22094467. Acesso em: 08 ago. 2024.APA
Gomes, F. V., & Grace, A. A. (2021). Beyond dopamine receptor antagonism: New targets for Schizophrenia treatment and prevention. International Journal of Molecular Sciences, 22( 9), 1-18. doi:10.3390/ijms22094467NLM
Gomes FV, Grace AA. Beyond dopamine receptor antagonism: New targets for Schizophrenia treatment and prevention [Internet]. International Journal of Molecular Sciences. 2021 ; 22( 9): 1-18.[citado 2024 ago. 08 ] Available from: https://doi.org/10.3390/ijms22094467Vancouver
Gomes FV, Grace AA. Beyond dopamine receptor antagonism: New targets for Schizophrenia treatment and prevention [Internet]. International Journal of Molecular Sciences. 2021 ; 22( 9): 1-18.[citado 2024 ago. 08 ] Available from: https://doi.org/10.3390/ijms22094467
